Invention Grant
- Patent Title: Antibody specifically binding to insulin-like growth factor-1
- Patent Title (中): 抗体与胰岛素样生长因子-1特异性结合
-
Application No.: US14069445Application Date: 2013-11-01
-
Publication No.: US09273144B2Publication Date: 2016-03-01
- Inventor: Herbert Andres , Hartmut Duefel , Michael Gerg , Frank Kowalewsky , Christian Scholz , Michael Schraeml
- Applicant: Roche Diagnostics Operations, Inc.
- Applicant Address: US IN Indianapolis
- Assignee: Roche Diagnostics Operations, Inc.
- Current Assignee: Roche Diagnostics Operations, Inc.
- Current Assignee Address: US IN Indianapolis
- Agency: Roche Diagnostics Operations, Inc.
- Priority: EP11164957 20110505; EP12155742 20120216
- Main IPC: C07K16/00
- IPC: C07K16/00 ; C07K16/40 ; C07K16/22 ; C12N9/90 ; C07K16/12 ; G01N33/74 ; G01N33/573

Abstract:
Isolated antibodies that specifically bind to an epitope comprised in the stretch of amino acids ranging from amino acid 76 to amino acid 84 of human insulin-like growth factor-1 precursor (SEQ ID NO:1). Use of the novel antibodies for the sensitive and specific detection of insulin-like growth factor-1, in some embodiments while in the presence of high excess concentration of insulin-like growth factor-2, for example in a bodily fluid sample.
Public/Granted literature
- US20140120561A1 ANTIBODY SPECIFICALLY BINDING TO INSULIN-LIKE GROWTH FACTOR-1 Public/Granted day:2014-05-01
Information query